Category: News & Articles
... fail. Who it works for now Nivolumab and pembrolizumab are checkpoint immunotherapy antibodies. They work by blocking barriers (or ... these drugs is with melanoma, which has long been known to respond to immunotherapy. In Australia, single or combination checkpoint immunotherapy substantially helps about half of people with melanoma , ...
Category: Research
Funding is requested to attend the Inaugural International Cancer Immunotherapy Conference, September 16 -19, 2015, in New York, New York, ... sponsored by the Cancer Research Institute, Association for Cancer Immunotherapy, European Academy of Tumor Immunology and American ... and will bring together leaders in the fields of immunology and immunotherapy to disseminate and discuss recent research discoveries to ...
Category: General
Cancer immunotherapy is a therapeutic strategy that harnesses cancer patients ... target cancer cells. A new class of newly developed drugs in cancer immunotherapy (called immune checkpoint inhibitors) can cause long ... our understanding of important aspects of gene regulation involving immunotherapy checkpoint inhibitors. This project will increase our ...
Category: Research
... is "targeting survival signalling pathways to sensitize melanoma to immunotherapy". Her research has drawn extensive attention from ... the melanoma field nationally and internationally. Research Combining immunotherapy and targeted therapy in the treatment of human melanoma ...
Category: News & Articles
... end stage melanoma whose cancers had become resistant to frontline immunotherapy treatment, a class of drugs known as Immune Checkpoint ... Azacitidine and Carboplatin could be effective in priming for anti-immunotherapy (Avelumab) in patients with advanced ICB-resistant ... repurposed chemo drugs in order to ‘prime’ them for a subsequent immunotherapy treatment. The patients survived an average of 47 weeks, ...
Category: General
The HMRI National Science Week Cancer Public Seminar will explore immunotherapy and the future of cancer treatment. National Science Week Public Seminar: Immunotherapy and other drugs: A future of cancer treatment What does ... The HMRI National Science Week Cancer Public Seminar will explore immunotherapy and the future of cancer treatment Cancer Public Seminar | ...
Category: General
... These cancers all respond exceptionally well to new drugs called immunotherapy that ‘take the breaks off’ the immune system and let ... also predict that the same patients will go on to respond well to immunotherapy. The HMRI Solution: HMRI researcher Dr Nikola Bowden is in the unique position of understanding the science of melanoma immunotherapy as well as ovarian drug therapy. She has a 5 year plan to ...
Category: General
... has spread beyond the original site. A new treatment approach called immunotherapy can cause long-lasting melanoma regression. However, only a small proportion of melanoma patients benefit from immunotherapy. Resistance of melanoma to these treatments is closely ... protects melanoma cells from death induced by targeted therapy and immunotherapy drugs. Understanding how theses cells evade death will ...
Category: News & Articles
... dying from the disease every year. Dr Kim has developed a two-pronged immunotherapy treatment for HGG by enhancing a patient’s immunity and ... new immunotherapeutic platform that can overcome many hurdles of the immunotherapy against the brain tumour,’’ Dr Kim said. “My approach is highly targeted, cost-effective combinatorial immunotherapy and also has the potential to target the residual brain ...
Category: News & Articles
... Encouragingly, researchers have recently made progress in optimising immunotherapy, also called peanut “desensitisation”. In this process ... a study with 28 children in Durham, North Carolina, showed that oral immunotherapy could reduce allergic reactions to peanut. This study was ... Institute, Melbourne, studied an oral probiotic peanut combination immunotherapy in 62 allergic children without previous anaphylaxis. ...
